Harvard Bioscience (HBIO) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.48% |
| Dec 31, 2025 | 107.18% |
| Sep 30, 2025 | 1.60% |
| Jun 30, 2025 | -28.27% |
| Mar 31, 2025 | -72.28% |
| Dec 31, 2024 | 18.23% |
| Sep 30, 2024 | -6.54% |
| Jun 30, 2024 | -61.76% |
| Mar 31, 2024 | -80.18% |
| Dec 31, 2023 | -26.46% |
| Sep 30, 2023 | -24.97% |
| Jun 30, 2023 | 32.50% |
| Mar 31, 2023 | 27.59% |
| Dec 31, 2022 | 64.82% |
| Sep 30, 2022 | -57.35% |
| Jun 30, 2022 | 75.95% |
| Mar 31, 2022 | -80.53% |
| Dec 31, 2021 | 28.57% |
| Sep 30, 2021 | 21.74% |
| Jun 30, 2021 | 15.65% |
| Mar 31, 2021 | -1.58% |
| Dec 31, 2020 | 54.79% |
| Sep 30, 2020 | 17.45% |
| Jun 30, 2020 | 41.22% |
| Mar 31, 2020 | -23.27% |
| Dec 31, 2019 | -5.09% |
| Sep 30, 2019 | -24.22% |
| Jun 30, 2019 | -33.38% |
| Mar 31, 2019 | -15.89% |
| Dec 31, 2018 | 30.85% |
| Sep 30, 2018 | 16.54% |
| Jun 30, 2018 | -20.23% |
| Mar 31, 2018 | -24.20% |
| Dec 31, 2017 | -29.44% |
| Sep 30, 2017 | -18.51% |
| Jun 30, 2017 | -16.09% |
| Mar 31, 2017 | -16.76% |
| Dec 31, 2016 | -22.95% |
| Sep 30, 2016 | -41.61% |
| Jun 30, 2016 | -18.47% |
| Mar 31, 2016 | -16.14% |
| Dec 31, 2015 | -47.84% |
| Sep 30, 2015 | -19.12% |
| Jun 30, 2015 | -47.02% |